371. Lentivirally Engineered Primary Human Peripheral Blood Lymphocytes with Anti-CEA Chimeric Immune Receptor Efficiently Recognize and Lyse CEA* Tumor Cells

doi:10.1016/s1525-0016(16)44577-6

371. Lentivirally Engineered Primary Human Peripheral Blood Lymphocytes with Anti-CEA Chimeric Immune Receptor Efficiently Recognize and Lyse CEA* Tumor Cells

Open Access

https://doi.org/10.1016/s1525-0016(16)44577-6

Copy DOI

Journal: Molecular Therapy	Publication Date: May 1, 2007
License type: cc-by-nc-nd

#Primary Human Peripheral Blood Lymphocytes #Primary Human Lymphocytes + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

371. Lentivirally Engineered Primary Human Peripheral Blood Lymphocytes with Anti-CEA Chimeric Immune Receptor Efficiently Recognize and Lyse CEA* Tumor Cells

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Molecular Therapy

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.